Stereotactic Body Radiation Therapy for Oligometastatic Renal Cell Carcinoma or Melanoma: Prognostic Factors and Outcomes

被引：5
|
作者：
Grossman, C. E. [1 ]
Okunieff, P. [2 ]
Brasacchio, R. A. [1 ]
Katz, A. W. [1 ]
Singh, D. P. [1 ]
Usuki, K. Y. [1 ]
Chen, Y. [1 ]
Milano, M. T. [3 ]
机构：
[1] Univ Rochester, Wilmot Canc Inst, Rochester, NY USA
[2] Univ Florida, Gainesville, FL USA
[3] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2015.07.1061
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2508
引用
收藏
页码：E202 / E202
页数：1
相关论文
共 50 条
  • [31] Stereotactic Body Radiation Therapy for Oligometastatic Spinal Disease
    Chaw, C. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E67 - E67
  • [32] Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control
    Stinauer, Michelle A.
    Kavanagh, Brian D.
    Schefter, Tracey E.
    Gonzalez, Rene
    Flaig, Thomas
    Lewis, Karl
    Robinson, William
    Chidel, Mark
    Glode, Michael
    Raben, David
    RADIATION ONCOLOGY, 2011, 6
  • [33] Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control
    Michelle A Stinauer
    Brian D Kavanagh
    Tracey E Schefter
    Rene Gonzalez
    Thomas Flaig
    Karl Lewis
    William Robinson
    Mark Chidel
    Michael Glode
    David Raben
    Radiation Oncology, 6
  • [34] Stereotactic Body Radiation Therapy for Melanoma and Renal Cell Carcinoma: Impact of Single Fraction Equivalent Dose on Local Control
    Stinauer, M. A.
    Kavanagh, B.
    Schefter, T.
    Gonzalez, R.
    Flaig, T.
    Lewis, K.
    Robinson, W.
    Chidel, M.
    Glode, M.
    Raben, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S190 - S191
  • [35] Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
    Sabine Gerum
    Christian Heinz
    Claus Belka
    Franziska Walter
    Philipp Paprottka
    Enrico N. De Toni
    Falk Roeder
    Radiation Oncology, 13
  • [36] Case Report: Stereotactic body radiation treatment for immunotherapy escaped oligometastatic progression in cutaneous melanoma and merkel cell carcinoma
    Khaddour, Karam
    Zhou, Alice
    Butt, Omar
    Huang, Jiayi
    Ansstas, George
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [37] Early Clinical Outcomes of Stereotactic Body Radiation Therapy (SBRT) for Oligometastatic Gynecological Malignancies
    Mesko, S.
    Kamrava, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E321 - E322
  • [38] Outcomes from Stereotactic Body Radiation Therapy (SBRT) for Oligometastatic Colorectal Cancer (CRC)
    Dayal, A.
    Rosser, C.
    Deng, M.
    Ruth, K.
    Denlinger, C.
    Meyer, J. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E564 - E565
  • [39] Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
    Gerum, Sabine
    Heinz, Christian
    Belka, Claus
    Walter, Franziska
    Paprottka, Philipp
    De Toni, Enrico N.
    Roeder, Falk
    RADIATION ONCOLOGY, 2018, 13
  • [40] Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapy
    Franzese, Ciro
    Comito, Tiziana
    Toska, Eno
    Tozzi, Angelo
    Clerici, Elena
    De Rose, Fiorenza
    Franceschini, Davide
    Navarria, Pierina
    Reggiori, Giacomo
    Tomatis, Stefano
    Scorsetti, Marta
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : 220 - 226
12345